McKay McKinnon

Last updated

McKay McKinnon is an American physician specializing in plastic surgery. He works in Chicago, Illinois and Miami, Florida.

Contents

He graduated from medical school at the University of North Carolina School of Medicine. He completed his general surgery residency at Harvard University and his plastic surgery residency at the University of Miami. He completed plastic surgery fellowships at Children's Hospital in Boston, Massachusetts, University of Miami, and in Paris, France. He formerly served on the faculty at the University of Chicago Medical Center and worked at Lurie Children's Hospital in Chicago, Illinois.

Tumor removal and craniofacial surgeries

In 1999, McKinnon treated a Michigan woman with a large tumor disorder, neurofibroma, at the University of Chicago. He removed her 200-pound tumor in an 18-hour operation that drew worldwide attention, according to USA Today. [1] [2] McKinnon was subsequently featured on the Oprah Winfrey Show for successfully removing the world’s biggest solid tumor. [3]

In 2004, McKinnon was invited on a mission to Romania to treat a similar patient with a giant neurofibroma tumor. With a team of doctors, he performed a 10-hour operation and successfully removed an 80-pound tumor from a 47-year-old woman that suffers from a genetic disorder causing tumors to grow on her body, according to BBC News. [4] [5] [6]

From 1985-2014 he led missions to Choluteca, Honduras where he performed cleft lip and palate and other reconstructive surgery. [7]

In 2011, on request of US 501(c) Tree of Life International, Sam-Ottawa of Canada-based Virtual Medical Miracle Network (VM2N) connected McKinnon to Nguyen Duy Hai of Dalat Lam Dong, Vietnam, who suffered from a non-cancerous tumor weighing 198-pound (90 kg), which was growing on the right side of his abdomen. A successful 12-hour operation was performed at French Vietnam Hospital in Saigon on January 5, 2012. [8]

In October 2012, McKinnon was featured in the television program My Giant Face Tumor on the TLC Network. In the program, he successfully removed large facial tumors from two patients, one in Ohio and the other in Thailand, who suffer from neurofibromatosis. [9]

Related Research Articles

<span class="mw-page-title-main">Neurosurgery</span> Medical specialty of disorders which affect any portion of the nervous system.

Neurosurgery or neurological surgery, known in common parlance as brain surgery, is the medical specialty concerned with the surgical treatment of disorders which affect any portion of the nervous system including the brain, spinal cord and peripheral nervous system.

<span class="mw-page-title-main">Neurofibromatosis</span> Three genetic disorders involving benign tumors of the nervous system

Neurofibromatosis (NF) refers to a group of three distinct genetic conditions in which tumors grow in the nervous system. The tumors are non-cancerous (benign) and often involve the skin or surrounding bone. Although symptoms are often mild, each condition presents differently. Neurofibromatosis type I (NF1) is typically characterized by café au lait spots, neurofibromas, scoliosis, and headaches. Neurofibromatosis type II (NF2), on the other hand, may present with early-onset hearing loss, cataracts, tinnitus, difficulty walking or maintain balance, and muscle atrophy. The third type is called schwannomatosis and often presents in early adulthood with widespread pain, numbness, or tingling due to nerve compression.

<span class="mw-page-title-main">Face transplant</span> Medical procedure to replace a persons face using donor tissue

A face transplant is a medical procedure to replace all or part of a person's face using tissue from a donor. Part of a field called "Vascularized Composite Tissue Allotransplantation" (VCA) it involves the transplantation of facial skin, the nasal structure, the nose, the lips, the muscles of facial movement used for expression, the nerves that provide sensation, and, potentially, the bones that support the face. The recipient of a face transplant will take life-long medications to suppress the immune system and fight off rejection.

<span class="mw-page-title-main">Vestibular schwannoma</span> Benign tumor of the vestibulocochlear cranial nerve

A vestibular schwannoma (VS), also called acoustic neuroma, is a benign tumor that develops on the vestibulocochlear nerve that passes from the inner ear to the brain. The tumor originates when Schwann cells that form the insulating myelin sheath on the nerve malfunction. Normally, Schwann cells function beneficially to protect the nerves which transmit balance and sound information to the brain. However, sometimes a mutation in the tumor suppressor gene, NF2, located on chromosome 22, results in abnormal production of the cell protein named Merlin, and Schwann cells multiply to form a tumor. The tumor originates mostly on the vestibular division of the nerve rather than the cochlear division, but hearing as well as balance will be affected as the tumor enlarges.

Spinal tumors are neoplasms located in either the vertebral column or the spinal cord. There are three main types of spinal tumors classified based on their location: extradural and intradural. Extradural tumors are located outside the dura mater lining and are most commonly metastatic. Intradural tumors are located inside the dura mater lining and are further subdivided into intramedullary and extramedullary tumors. Intradural-intramedullary tumors are located within the dura and spinal cord parenchyma, while intradural-extramedullary tumors are located within the dura but outside the spinal cord parenchyma. The most common presenting symptom of spinal tumors is nocturnal back pain. Other common symptoms include muscle weakness, sensory loss, and difficulty walking. Loss of bowel and bladder control may occur during the later stages of the disease.

Oral and maxillofacial surgery is a surgical specialty focusing on reconstructive surgery of the face, facial trauma surgery, the oral cavity (mouth), head and neck, and jaws, as well as facial cosmetic surgery/facial plastic surgery including cleft lip and cleft palate surgery.

<span class="mw-page-title-main">Neurofibromatosis type I</span> Type of neurofibromatosis disease

Neurofibromatosis type I (NF-1), or von Recklinghausen syndrome, is a complex multi-system human disorder caused by the mutation of neurofibromin 1 (NF-1), a gene on chromosome 17 that is responsible for production of a protein (neurofibromin) which is needed for normal function in many human cell types. NF-1 causes tumors along the nervous system which can grow anywhere on the body. NF-1 is one of the most common genetic disorders and is not limited to any person's race or sex. NF-1 is an autosomal dominant disorder, which means that mutation or deletion of one copy of the NF-1 gene is sufficient for the development of NF-1, although presentation varies widely and is often different even between relatives affected by NF-1.

<span class="mw-page-title-main">Neurofibromatosis type II</span> Type of neurofibromatosis disease

Neurofibromatosis type II is a genetic condition that may be inherited or may arise spontaneously, and causes benign tumors of the brain, spinal cord, and peripheral nerves. The types of tumors frequently associated with NF2 include vestibular schwannomas, meningiomas, and ependymomas. The main manifestation of the condition is the development of bilateral benign brain tumors in the nerve sheath of the cranial nerve VIII, which is the "auditory-vestibular nerve" that transmits sensory information from the inner ear to the brain. Besides, other benign brain and spinal tumors occur. Symptoms depend on the presence, localisation and growth of the tumor(s). Many people with this condition also experience vision problems. Neurofibromatosis type II is caused by mutations of the "Merlin" gene, which seems to influence the form and movement of cells. The principal treatments consist of neurosurgical removal of the tumors and surgical treatment of the eye lesions. Historically the underlying disorder has not had any therapy due to the cell function caused by the genetic mutation.

<span class="mw-page-title-main">Neurofibroma</span> Benign nerve-sheath tumor in the peripheral nervous system

A neurofibroma is a benign nerve-sheath tumor in the peripheral nervous system. In 90% of cases, they are found as stand-alone tumors, while the remainder are found in persons with neurofibromatosis type I (NF1), an autosomal-dominant genetically inherited disease. They can result in a range of symptoms from physical disfiguration and pain to cognitive disability.

Phakomatoses, also known as neurocutaneous syndromes, are a group of multisystemic diseases that most prominently affect structures primarily derived from the ectoderm such as the central nervous system, skin and eyes. The majority of phakomatoses are single-gene disorders that may be inherited in an autosomal dominant, autosomal recessive or X-linked pattern. Presentations may vary dramatically between patients with the same particular syndrome due to mosaicism, variable expressivity, and penetrance.

Fred J. Epstein was a pediatric neurosurgeon credited for the development of pioneering neurosurgical techniques to treat children threatened by brain and spinal-cord tumors.

<span class="mw-page-title-main">Neurofibromin</span> Mammalian protein found in humans

Neurofibromin (NF-1) is a protein that is encoded in the human by the NF1 gene. NF1 is located on chromosome 17. Neurofibromin, a GTPase-activating protein that negatively regulates RAS/MAPK pathway activity by accelerating the hydrolysis of Ras-bound GTP. NF1 has a high mutation rate and mutations can alter cellular growth control, and neural development, resulting in neurofibromatosis type 1. Symptoms of NF1 include disfiguring cutaneous neurofibromas (CNF), café au lait pigment spots, plexiform neurofibromas (PN), skeletal defects, optic nerve gliomas, life-threatening malignant peripheral nerve sheath tumors (MPNST), pheochromocytoma, attention deficits, learning deficits and other cognitive disabilities.

<span class="mw-page-title-main">Loyola University Medical Center</span> Hospital in Illinois, United States

Loyola Medicine, also known as Loyola University Health System, is a quaternary-care system with a 61-acre (25 ha) main medical center campus in the western suburbs of Chicago, in the U.S. state of Illinois. The medical center campus is located in Maywood, 13 miles (21 km) west of the Chicago Loop and 8 miles (13 km) east of Oak Brook. The heart of the medical center campus is the Loyola University Medical Center. Also on campus are the Joseph Cardinal Bernardin Cancer Center Loyola Outpatient Center, Center for Heart & Vascular Medicine and Loyola Oral Health Center as well as the Loyola University Chicago Stritch School of Medicine, Loyola University Chicago Marcella Niehoff School of Nursing, Center for Translational Research and Education, and the Loyola Center for Fitness.

Marlie Mychele Casseus was a Haitian woman who attracted national and international media attention when she received surgery to remove a 7-kg (18-pound) growth from her face that threatened her ability to eat, hear, breathe and see.

International Kids Fund (IKF) is a non-profit, philanthropic program of Jackson Memorial Foundation committed to helping critically ill children primarily from Latin America and the Caribbean gain immediate access to essential medical treatments that are unavailable in their respective home countries.

Tomoaki Kato is a pioneer in multiple-organ transplantation, pediatric and adult liver transplantation. Kato is Surgical Director of Adult and Pediatric Liver and Intestinal Transplantation at NewYork-Presbyterian Hospital/Columbia University Medical Center and is a professor of surgery at Columbia University College of Physicians and Surgeons. Kato is also known for unique and innovative surgeries for adults and children, including a six-organ transplant; a procedure called APOLT that resuscitates a failing liver by attaching a partial donor liver, making immunosuppressant drugs unnecessary; and the first successful human partial bladder transplantation involving the transplant of two kidneys together with ureters connected to a patch of the donor bladder. In a highly publicized case, he led the first reported removal and re-implantation, or auto-transplantation, of six organs to excise a hard-to-reach abdominal tumor. Previously the director of pediatric liver and gastrointestinal transplant and professor of clinical surgery at the University of Miami School of Medicine, Kato received his medical degree from the Osaka University Medical School in Japan and received his residency training in surgery at Osaka University Hospital and Itami City Hospital in Hyogo, Japan. He completed a clinical fellowship in transplantation at the University of Miami/Jackson Memorial Hospital, in Miami, Florida, where he was subsequently appointed to the surgical faculty in 1997, and promoted to full professor in 2007. He served as a surgeon and senior leader of the liver and transplantation center at Miami's Jackson Memorial Hospital, beginning in 1997, and at University of Miami Hospital, beginning in 2004. Kato is a member of numerous professional and honorary organizations, and the author or co-author of more than 180 scientific papers in peer-reviewed journals.

<span class="mw-page-title-main">Ramakanta Panda</span> Indian cardiologist

Ramakanta Panda, MCh, is the chief consultant for cardiovascular thoracic surgery and the group CEO of the Asian Heart Institute, a speciality cardiac care hospital under the aegis of Asian Hospitals, at the Bandra-Kurla Complex in Mumbai, India. In 2002, he set up the Asian Heart Institute in India. Panda has performed about 28,000 successful cardiac surgeries as of 2022, including over 1,900 redo bypass surgeries. He was awarded the Padma Bhushan in 2010 by the Government of India. Known as "the man with the safest hands".

Huang Chuncai is a Chinese man who became notable for being "China's Elephant man". He has an extreme case of neurofibromatosis, which caused such large tumors on his face that they had completely distorted his features.

Michael J. Reardon is an American cardiac surgeon and medical researcher. He is known for his work in heart autotransplantation for malignant heart tumors, an operation in which the surgeon removes the patient's heart, cuts out the malignant tumor, and reimplants the heart back in the patient's chest. He performed the first successful heart autotransplantation for a cancerous heart tumor in 1998.

Neuroplastic or neuroplastic and reconstructive surgery is the surgical specialty involved in reconstruction or restoration of patients who undergo surgery of the central or peripheral nervous system. The field includes a wide variety of surgical procedures that seek to restore or replace a patient's skull, face, scalp, dura, the spine and/or its overlying tissues.

References

  1. "Super Surgery: 200 Pound Tumor (TV 2002) - IMDb". Us.imdb.com. 2009-05-01. Retrieved 2011-08-06.
  2. "Yahoo!". television.aol.com.
  3. "How Big is the Biggest Tumor? (with pictures)". wiseGEEK. Retrieved 2020-03-19.
  4. "Health | Giant tumor removed from woman". BBC News. 2004-01-22. Retrieved 2011-08-06.
  5. "Giant Tumor Successfully Removed". CBS News. Retrieved 2011-08-06.
  6. "Megatumour - 11 stone parasite". Mymultiplesclerosis.co.uk. 2008-07-15. Retrieved 2011-08-06.
  7. "Cirujano de Clase Mundial Cambia Vidas". Extra News. Archived from the original on 2011-07-23. Retrieved 2011-08-06.
  8. "Vietnamese man has massive 200-lb tumor removed from leg" . Retrieved 2018-05-05.
  9. ""My Giant Face Tumor" Makes Neurofibromatosis Personal". TLC NewNow. Discovery.com. October 9, 2012. Retrieved October 17, 2012.

Further reading